Cargando…

PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer

The role of PTPRT in breast cancer was not comprehensively explored and well analyzed. Our study comprehensively searched available databases to analyze the clinical role of PTPRT in breast cancer. We found PTPRT was an antioncogene and could be used to distinguish different stages, age groups, mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lun, Xu, Feng, Xie, Pingfang, Yuan, Liqin, Zhou, Meirong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370817/ https://www.ncbi.nlm.nih.gov/pubmed/34414233 http://dx.doi.org/10.1155/2021/3301402

Ejemplares similares

Association of PTPRT Mutations with Cancer Metastasis in Multiple Cancer Types
por: Chen, Chao, et al.
Publicado: (2022)

PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types
por: Shang, Xiaoling, et al.
Publicado: (2022)

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients
por: Hsu, Hung-Chih, et al.
Publicado: (2018)

PTPRT Regulates High-Fat Diet-Induced Obesity and Insulin Resistance
por: Feng, Xiujing, et al.
Publicado: (2014)

Protein tyrosine phosphatase PTPRT as a regulator of synaptic formation and neuronal development
por: Lee, Jae-Ran
Publicado: (2015)

Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2019)

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades
por: Wang, Xiaoyan, et al.
Publicado: (2021)

Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans
por: Mitchell, Khadijah A., et al.
Publicado: (2020)

Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
por: Zhang, Wenjing, et al.
Publicado: (2021)

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis
por: Zhao, Yiqing, et al.
Publicado: (2016)

HSPA5 Could Be a Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Long non-coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4
por: Xiong, Xiang, et al.
Publicado: (2020)

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer
por: Bai, Xiaoyu, et al.
Publicado: (2022)

Corrigendum to GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer
Publicado: (2022)

β1,6 GlcNAc Branches-Modified PTPRT Attenuates Its Activity and Promotes Cell Migration by STAT3 Pathway
por: Qi, Jingjing, et al.
Publicado: (2014)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

Prognostic and Predictive Biomarkers in Familial Breast Cancer
por: Deb, Siddhartha, et al.
Publicado: (2023)

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023)

Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer
por: Liu, Hui, et al.
Publicado: (2022)

Current Treatments for Breast Cancer-Related Lymphoedema: A Systematic Review
por: Li, Lun, et al.
Publicado: (2016)

Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer
por: Feng, Dechao, et al.
Publicado: (2022)

Circulating proteins as predictive and prognostic biomarkers in breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2022)

PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
por: Qiao, Hao, et al.
Publicado: (2023)

Age-associated prognostic and predictive biomarkers in patients with breast cancer
por: Kolečková, Markéta, et al.
Publicado: (2017)

Cell division cycle proteinising prognostic biomarker of breast cancer
por: Cheng, Lin, et al.
Publicado: (2020)

Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
por: Zhang, Yaoting, et al.
Publicado: (2022)

AVL9 is Upregulated in and Could Be a Predictive Biomarker for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

A Systemic Inflammation Response Score for Prognostic Prediction of Breast Cancer Patients Undergoing Surgery
por: Zhang, Kaiming, et al.
Publicado: (2021)

Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma
por: He, Xuanhong, et al.
Publicado: (2022)

Breast cancer survival prediction using seven prognostic biomarker genes
por: Liu, Liu, et al.
Publicado: (2019)

RMI2 is a novel prognostic and predictive biomarker for breast cancer
por: Zhang, Lijie, et al.
Publicado: (2022)

Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions
por: Wang, Shenkangle, et al.
Publicado: (2023)

HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer
por: Wang, Tian, et al.
Publicado: (2022)

The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients
por: Zhang, Jing, et al.
Publicado: (2022)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Identification and validation of tumor microenvironment-related prognostic biomarkers in breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
por: Alexandre, Marie, et al.
Publicado: (2019)

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer
por: Strizzi, Luigi, et al.
Publicado: (2012)

The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling
por: Verret, Benjamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17a3018uoma6bl7011k80q74co